Publications by the researcher in collaboration with María Jesús Lamas Díaz (20)

2019

  1. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients

    International Journal of Pharmaceutics, Vol. 567

  2. Therapeutic approach in fungal keratitis

    Mycotic Keratitis (CRC Press), pp. 189-216

2018

  1. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis

    Journal of Pharmaceutical Sciences, Vol. 107, Núm. 5, pp. 1342-1351

  2. Preclinical characterization and clinical evaluation of tacrolimus eye drops

    European Journal of Pharmaceutical Sciences, Vol. 120, pp. 152-161

  3. Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis

    Pharmaceutics, Vol. 10, Núm. 2

2017

  1. Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 678-687

  2. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging

    International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722

  3. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209

  4. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  5. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  6. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the hospital pharmacy departments

    Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 352-370

  2. La optimización de las formulaciones magistrales oftálmicas en los servicios de farmacia hospitalaria

    El Farmacéutico. Hospitales, Núm. 207, pp. 4-14

  3. Ophthalmic formulations new goals

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

  4. Síndrome serotoninérgico con rabdomiolisis y convulsiones asociado a la interacción farmacológica entre venlafaxina y amoxicilina-clavulánico

    Actas Espanolas de Psiquiatria

2015

  1. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 342-351

  2. Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention

    International Journal of Pharmaceutics, Vol. 495, Núm. 2, pp. 680-691

2014

  1. Análisis de la toxicidad ocular de los colirios de voriconazol y fluconazol con HET-CAM

    Farmacia Hospitalaria, Vol. 38, Núm. 4, pp. 300-304

  2. Lubricantes oculares en el tratamiento del ojo seco

    Panorama actual del medicamento, Vol. 38, Núm. 372, pp. 350-356

  3. Use of fortified antibiotic eye drops on eye infections

    Atencion Farmaceutica, Vol. 16, Núm. 4, pp. 296-299